4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
CONGENITAL LEUKEMIA & HYPOPLASTIC PRELEUKEMIA
Congenital Leukemia & Hypoplastic Preleukemia
Dr. Bharat R. Agarwal
Pediatric Hematologist-Oncologist, Division of Pediatric Hem-Onco,
B.J. Wadia Hospital for Children


CONGENITAL LEUKEMIA

Leukemia diagnosed from birth to 6 weeks of age is defined as congenital leukemia. This is a rare disease. Its etiology is unknown. Congenital leukemia has been associated with:

A few examples of congenital JMML have been reported.

 Clinical features
  • Nodular skin infiltrates (bluish, fibroma-like tumors, leukemia cutis)

  • Hepatosplenomegaly

  • Lethargy, poor feeding, pallor

  • Purpura / petechiae

  • Respiratory distress

 Laboratory studies
  • Usually monocytic subtype of ANLL.

  • Occasionally ALL (pre-B immunophenotype)
 Management
  • Congenital leukemia in Down syndrome :

    • Therapy should be withheld as long as possible, because spontaneous remission may occasionally occur.

    • If disease progresses, hematological or clinical condition deteriorates, appropriate chemotherapy can be administered.

  • Congenital leukemia with normal blast cell karyotype:

    • Therapy should be withheld, because spontaneous remission may occasionally occur.

    • If the disease progresses, appropriate therapy can be administered.

  • Congenital leukemia with chromosomal anomalies in blast cells: This leukemia progresses clinically and hematologically and requires institution of therapy.

 Treatment

Treatment involves intensive therapy with VP16 or VM-26. This treatment has been found effective in acute monoblastic leukemia of infancy and neonatal leukemia. Allogenic bone marrow transplantation, if a suitably matched bone marrow donor is available, may be indicated when patient is in remission.

 HYPOPLASTIC PRELEUKEMIA

A small number of patients who ultimately develop acute leukemia are initially diagnosed as having aplastic anemia. The illness is characterized by :-

  • Pancytopenia or single cytopenia

  • Hypocellular bone marrow

  • No hepatosplenomegaly

  • Diagnosis of leukemia 1-9 months after onset of symptoms.
In 1-2% of childhood leukemias, the presentation includes initial marrow failure and may represent 5% of childhood acquired aplastic anemia.

 Treatment
  • Supportive transfusions initially

  • Specific antileukemic chemotherapy, when leukemia is diagnosed
Last created on 24-06-2002
Last updated on 01-07-2006

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us